Vanderbilt researchers have found that selenium deficiency may contribute to the racial disparity in lung cancer incidence.
Researchers in the Vanderbilt University Institute of Imaging Science have achieved the first conclusive non-invasive measurement of neural signaling in the spinal cords of healthy human volunteers.
Vanderbilt investigators have constructed a network map that could guide the development of new targeted cancer therapies.
Vanderbilt researchers have discovered that the protein CRADD counteracts inflammatory injury to endothelial cells, which could assist the development of new therapies for inflammatory vascular disorders.
Vanderbilt University’s Cyndya Shibao, M.D., MSCI, has received a Clinical Scientist Development Award from the Doris Duke Charitable Foundation.
Vanderbilt University researchers have received a five-year, $1.2 million grant from the Fogarty International Center of the National Institutes of Health (NIH) to strengthen research ethics capacity in Mozambique.
Accessibility Tools